Vaccinating pregnant women with new RSV vaccine helped protect newborns: Pfizer - National
Pfizer's maternal vaccine is the same recipe it tested successfully in older adults and it plans to seek Food and Drug Administration approval for those vaccinations by year's end.
Strong RSV vaccine data lifts hopes after years of futility
New research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.
After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year
Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that it will end enrollment in the study and submit for US Food and Drug Administration approval by the end of the year.